Verve Therapeutics (VERV) News Today $4.79 -0.59 (-10.97%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Research Analysts Set Expectations for VERV FY2024 EarningsNovember 15 at 1:13 AM | americanbankingnews.comVERV FY2024 EPS Estimate Boosted by Cantor FitzgeraldVerve Therapeutics, Inc. (NASDAQ:VERV - Free Report) - Cantor Fitzgerald lifted their FY2024 earnings per share estimates for Verve Therapeutics in a note issued to investors on Monday, November 11th. Cantor Fitzgerald analyst R. Bienkowski now anticipates that the company will post earnings perNovember 14 at 8:16 AM | marketbeat.comHC Wainwright Analysts Reduce Earnings Estimates for VERVNovember 10, 2024 | americanbankingnews.comWhat is Lifesci Capital's Estimate for VERV FY2024 Earnings?November 9, 2024 | americanbankingnews.comWhat is HC Wainwright's Estimate for VERV FY2024 Earnings?Verve Therapeutics, Inc. (NASDAQ:VERV - Free Report) - Stock analysts at HC Wainwright cut their FY2024 earnings estimates for Verve Therapeutics in a research note issued to investors on Wednesday, November 6th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings ofNovember 8, 2024 | marketbeat.comResearch Analysts Offer Predictions for VERV FY2024 EarningsVerve Therapeutics, Inc. (NASDAQ:VERV - Free Report) - Research analysts at Lifesci Capital lifted their FY2024 earnings estimates for shares of Verve Therapeutics in a research report issued on Tuesday, November 5th. Lifesci Capital analyst C. Jubinville now anticipates that the company will posNovember 8, 2024 | marketbeat.comFY2024 Earnings Estimate for VERV Issued By William BlairVerve Therapeutics, Inc. (NASDAQ:VERV - Free Report) - Investment analysts at William Blair upped their FY2024 earnings per share estimates for shares of Verve Therapeutics in a report issued on Tuesday, November 5th. William Blair analyst M. Minter now forecasts that the company will post earninNovember 8, 2024 | marketbeat.comCanaccord Genuity Group Raises Verve Therapeutics (NASDAQ:VERV) Price Target to $32.00November 8, 2024 | americanbankingnews.comHC Wainwright Lowers Verve Therapeutics (NASDAQ:VERV) Price Target to $14.00November 8, 2024 | americanbankingnews.comVerve Therapeutics price target lowered to $17 from $20 at RBC CapitalNovember 6, 2024 | markets.businessinsider.comVerve Therapeutics Reports Q3 Progress and FinancialsNovember 6, 2024 | markets.businessinsider.comPositive Outlook on Verve Therapeutics: Promising VERVE-102 Trial Results and Genetic Editing AdvancementsNovember 6, 2024 | markets.businessinsider.comHC Wainwright Has Lowered Expectations for Verve Therapeutics (NASDAQ:VERV) Stock PriceHC Wainwright lowered their price objective on shares of Verve Therapeutics from $15.00 to $14.00 and set a "buy" rating on the stock in a research note on Wednesday.November 6, 2024 | marketbeat.comVerve Therapeutics Positioned for Growth with Promising Clinical Progress and Strategic ExpansionNovember 6, 2024 | markets.businessinsider.comVerve Therapeutics Third Quarter 2024 Earnings: Beats ExpectationsNovember 6, 2024 | finance.yahoo.comVerve Therapeutics (NASDAQ:VERV) Trading Up 10.1% - Here's What HappenedVerve Therapeutics (NASDAQ:VERV) Trading Up 10.1% - Still a Buy?November 5, 2024 | marketbeat.comVerve Therapeutics sees cash runway through 2026November 5, 2024 | markets.businessinsider.comVerve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial ResultsNovember 5, 2024 | finance.yahoo.comVerve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)November 1, 2024 | globenewswire.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve TherapeuticsOctober 29, 2024 | markets.businessinsider.comFINAL VERV DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Verve Therapeutics, Inc. Investors to Join the Class Action LawsuitOctober 28, 2024 | markets.businessinsider.comVERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law FirmOctober 28, 2024 | prnewswire.comVerve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERVOctober 28, 2024 | prnewswire.comVerve Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERVOctober 28, 2024 | prnewswire.comVERV DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERVOctober 27, 2024 | globenewswire.comVERV DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action...October 27, 2024 | markets.businessinsider.comVERV Deadline: Rosen Law Firm Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities ...October 26, 2024 | businesswire.comVERV Deadline: Rosen Law Firm Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERVOctober 26, 2024 | businesswire.comVERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law FirmOctober 25, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc. - VERVOctober 25, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve TherapeuticsOctober 25, 2024 | prnewswire.comVERV DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERVOctober 24, 2024 | globenewswire.comVerve Therapeutics (NASDAQ:VERV) Trading Up 7% - What's Next?Verve Therapeutics (NASDAQ:VERV) Stock Price Up 7% - What's Next?October 24, 2024 | marketbeat.comVerve Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff MotionOctober 23, 2024 | globenewswire.comVerve Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights – VERVOctober 23, 2024 | globenewswire.comVerve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERVOctober 23, 2024 | prnewswire.comInvestors who lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about pending Class Action - VERVOctober 23, 2024 | prnewswire.comVERV FINAL DEADLINE: RLF, RECOGNIZED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERVOctober 22, 2024 | globenewswire.comVERV Deadline: VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud LawsuitOctober 21, 2024 | prnewswire.comVERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law FirmOctober 21, 2024 | prnewswire.comVERV SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!October 20, 2024 | globenewswire.comVERV DEADLINE: RLF, THE FIRST FILING FIRM, Encourages Verve Therapeutics, Inc. Investors With Losses in Excess of 100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERVOctober 19, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc. - VERVOctober 17, 2024 | prnewswire.comVerve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERVOctober 17, 2024 | prnewswire.comState Street Corp's Strategic Acquisition in Verve TherapeuticsOctober 16, 2024 | finance.yahoo.comOctober 28, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against VERVOctober 16, 2024 | globenewswire.comVERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law FirmOctober 16, 2024 | prnewswire.comROSEN, A TOP RANKED LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERVOctober 15, 2024 | globenewswire.comShareholders that lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about pending Class Action - VERVOctober 15, 2024 | prnewswire.comVERV SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!October 14, 2024 | globenewswire.com Get Verve Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERV and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. VERV Media Mentions By Week VERV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERV News Sentiment▼0.600.56▲Average Medical News Sentiment VERV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERV Articles This Week▼106▲VERV Articles Average Week Get Verve Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Scholar Rock News Today Recursion Pharmaceuticals News Today Mirum Pharmaceuticals News Today Harmony Biosciences News Today Wave Life Sciences News Today Centessa Pharmaceuticals News Today Nurix Therapeutics News Today Disc Medicine News Today Spyre Therapeutics News Today Tarsus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VERV) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERV Stock Alerts